Skip to main content
AAN.com
brief communications expedited publication
May 1, 1995

A leucine‐to‐phenylalanine substitution in the acetylcholine receptor ion channel in a family with the slow‐channel syndrome

May 1995 issue
45 (5) 982-985

Abstract

Article abstract—The slow-channel syndrome is one of several congenital myasthenic syndromes that result from inherited abnormalities of the ion channel of the skeletal muscle acetylcholine receptor (AChR). The ion channel is formed by the second transmembrane domains (M2) of the four AChR subunits. We screened the genomic DNA of one family with the slow-channel syndrome for mutations in the coding sequences for the M2 domains of the four AChR subunits and report the identification of a missense mutation that causes a leucine-to-phenylalanine substitution at position 269 of the E subunit in three affected members of a family with the slow-channel syndrome. We propose that this mutation may be responsible for the disease.

Get full access to this article

View all available purchase options and get full access to this article.

Information & Authors

Information

Published In

Neurology®
Volume 45Number 5May 1995
Pages: 982-985
PubMed: 7538206

Publication History

Published online: May 1, 1995
Published in print: May 1995

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

C. M. Gomez, MD, PhD
From the Department of Neurology (Dr. Gomez and J. Gammack) and the Institute of Human Genetics (Dr. Gomez), University of Minnesota Medical School, Minneapolis, MN.
J. T. Gammack, BS
From the Department of Neurology (Dr. Gomez and J. Gammack) and the Institute of Human Genetics (Dr. Gomez), University of Minnesota Medical School, Minneapolis, MN.

Metrics & Citations

Metrics

Citation information is sourced from Crossref Cited-by service.

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Clinical and Pathologic Features of Congenital Myasthenic Syndromes Caused by 35 Genes—A Comprehensive Review, International Journal of Molecular Sciences, 24, 4, (3730), (2023).https://doi.org/10.3390/ijms24043730
    Crossref
  2. ALX 1‐ related frontonasal dysplasia results from defective neural crest cell development and migration , EMBO Molecular Medicine, 12, 10, (2020).https://doi.org/10.15252/emmm.202012013
    Crossref
  3. Determinants of the repetitive-CMAP occurrence and therapy efficacy in slow-channel myasthenia, Neurology, 95, 20, (e2781-e2793), (2020)./doi/10.1212/WNL.0000000000010734
    Abstract
  4. Rare slow channel congenital myasthenic syndromes without repetitive compound muscle action potential and dramatic response to low dose fluoxetine, Acta Neurologica Belgica, 121, 6, (1755-1760), (2020).https://doi.org/10.1007/s13760-020-01505-0
    Crossref
  5. Congenital myasthenic syndromes, Orphanet Journal of Rare Diseases, 14, 1, (2019).https://doi.org/10.1186/s13023-019-1025-5
    Crossref
  6. Slow‐channel myasthenia due to novel mutation in M2 domain of AChR delta subunit, Annals of Clinical and Translational Neurology, 6, 10, (2066-2078), (2019).https://doi.org/10.1002/acn3.50902
    Crossref
  7. Congenital myasthenic syndromes in Turkey: Clinical clues and prognosis with long term follow-up, Neuromuscular Disorders, 28, 4, (315-322), (2018).https://doi.org/10.1016/j.nmd.2017.11.013
    Crossref
  8. A Missense Mutation in Epsilon-subunit of Acetylcholine Receptor Causing Autosomal Dominant Slow-channel Congenital Myasthenic Syndrome in a Chinese Family, Chinese Medical Journal, 129, 21, (2596-2602), (2016).https://doi.org/10.4103/0366-6999.192780
    Crossref
  9. REVIEW ■ : Molecular Basis of Congenital Myasthenic Syndromes: Mutations in the Acetylcholine Receptor, The Neuroscientist, 4, 3, (185-194), (2016).https://doi.org/10.1177/107385849800400314
    Crossref
  10. NEW PERSPECTIVES IN PEDIATRIC NEUROMUSCULAR DISORDERS Hotel Intercontinental Sydney, Sydney, Australia, August 28, 1998, Journal of Child Neurology, 14, 1, (26-57), (2016).https://doi.org/10.1177/088307389901400103
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Figures

Tables

Media

Share

Share

Share article link

Share